You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for New Drug Application (NDA): 216278

✉ Email this page to a colleague

« Back to Dashboard

NDA 216278 describes TIOPRONIN, which is a drug marketed by Amneal, Endo Operations, Teva Pharms Inc, Torrent, and Teva Pharms Usa Inc, and is included in six NDAs. It is available from five suppliers. Additional details are available on the TIOPRONIN profile page.

The generic ingredient in TIOPRONIN is tiopronin. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tiopronin profile page.

Summary for 216278

Tradename:	TIOPRONIN
Applicant:	Amneal
Ingredient:	tiopronin
Patents:	0

Pharmacology for NDA: 216278

Mechanism of Action	Cystine Disulfide Reduction

Suppliers and Packaging for NDA: 216278

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TIOPRONIN	tiopronin	TABLET, DELAYED RELEASE;ORAL	216278	ANDA	Amneal Pharmaceuticals NY LLC	60219-2009	60219-2009-9	90 TABLET, DELAYED RELEASE in 1 BOTTLE (60219-2009-9)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, DELAYED RELEASE;ORAL			Strength	300MG
Approval Date:	Aug 15, 2023	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.